glp-1 drugs list 2024 GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities Mapping the effectiveness and risks

Apperloo EM, Neuen BL, Fletcher RA, et al

Additionally, the FDA recommends that these medications not be taken during pregnancy and be discontinued at least two months prior to pregnancy, because studies in rats, rabbits, and monkeys demonstrated that animals treated with these medications had higher rates of miscarriage, were born smaller, and were more likely to have birth defects

& Wheeler, M

A double-blinded placebo-controlled phase 2 clinical study in obese patients weekly injections of mazdutide (9 mg) could cause 15.4% decreases in body weight over placebo after 24 weeks

A mix of disrupted biological processes, such as oxidative stress, problems with cell repair, aging cells, and the release of inflammatory molecules, causes OA

Given the evolving nature of this novel topic, this systematic review included well-researched systematic reviews and meta-analysessourced both internationally and from less readily accessible databasesas they contributed a greater depth and breadth of information